URETER UROTHELIAL CARCINOMA
Clinical trials for URETER UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new URETER UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for URETER UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy targets Hard-to-Treat urinary cancers
Disease control OngoingThis early-phase study tests two or three drugs together (cabozantinib, nivolumab, and sometimes ipilimumab) in people with advanced cancers of the urinary and genital systems that have spread. The main goals are to find the safest dose and understand side effects. About 152 adul…
Matched conditions: URETER UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 10:56 UTC
-
Immunotherapy combo shows promise for tough bladder cancer
Disease control OngoingThis early-phase study tested two immunotherapy drugs (durvalumab and tremelimumab) given before surgery to people with muscle-invasive bladder cancer who cannot receive standard chemotherapy. The main goal was to check safety and side effects. Researchers also looked at whether …
Matched conditions: URETER UROTHELIAL CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 19, 2026 11:56 UTC